Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Sorrento Up on Request for Emergency Authorization for Covid Test
By Dan Weil
Dec 23, 2020 2:55 PM EST
PRESS RELEASES
Lee's Pharmaceutical Announces Its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Breakthrough Therapy Designation In China For The Treatment Of Recurrent Or Metastatic Cervical Cancer
By GlobeNewswire
Feb 9, 2021 9:00 AM EST
PRESS RELEASES
Sorrento Announces Subsidiary Company - ADNAB, Inc. - To Develop And Commercialize ADNAB™ Platform Products For Hematological Malignancies And Solid Tumors Based On An Exclusive Technology License From The Mayo Clinic
By GlobeNewswire
Feb 8, 2021 3:21 PM EST
PRESS RELEASES
Update To 01/26/21 COVI-MSC™ Press Release: Fourth Patient Also Released From Hospital Following Third Infusion Of Stem Cells
By GlobeNewswire
Jan 31, 2021 5:27 PM EST
PRESS RELEASES
Sorrento Announces Positive Preliminary Results Of Phase 1b Study Of COVI-MSC™ For Treatment Of ICU COVID-19 Patients
By GlobeNewswire
Jan 26, 2021 7:09 PM EST
PRESS RELEASES
Sorrento To Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
By GlobeNewswire
Jan 19, 2021 5:05 PM EST
PRESS RELEASES
Dr. Henry Ji To Participate In A Fireside Chat At The B. Riley Securities Oncology Investor Conference On Jan 20, 2021
By GlobeNewswire
Jan 19, 2021 2:05 AM EST
PRESS RELEASES
Dr. Henry Ji To Participate In The H.C. Wainwright Bioconnect 2021 Virtual Investor Conference
By GlobeNewswire
Jan 10, 2021 5:58 PM EST
PRESS RELEASES
Sorrento Announces The Submission Of A Marketing Authorization Application To COFEPRIS (Mexico) For COVI-STIX™ Rapid Detection Test Of SARS-CoV-2 Viral Antigen
By GlobeNewswire
Dec 30, 2020 12:47 PM EST
INVESTING
Sorrento Up on Request for Emergency Authorization for Covid Test
By Dan Weil
Dec 23, 2020 2:55 PM EST
PRESS RELEASES
Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application To The FDA For COVI-STIX™ Rapid Test For The Detection Of SARS-CoV-2 Viral Antigen
By GlobeNewswire
Dec 22, 2020 6:59 PM EST
PRESS RELEASES
Sorrento Receives US FDA Clearance To Proceed With Phase 1 Clinical Trials For STI-2020 (COVI-AMG) In Healthy Volunteers And In Newly Diagnosed COVID-19 Patients
By GlobeNewswire
Dec 9, 2020 9:00 AM EST
PRESS RELEASES
Sorrento Receives Licensure From The State Of California For Clinical Testing Laboratory (CLIA) Allowing For Clinical Sample Testing
By GlobeNewswire
Dec 8, 2020 8:05 PM EST
PRESS RELEASES
Sorrento To Participate In The 32nd Piper Sandler Healthcare Investor Conference
By GlobeNewswire
Nov 29, 2020 8:19 PM EST
INVESTING
Sorrento Receives $34M Federal Contract for Covid Treatment
By Dan Weil
Nov 27, 2020 10:37 AM EST
PRESS RELEASES
DARPA And JPEO Award Contract To SmartPharm, A Subsidiary Of Sorrento, For Development Of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
By GlobeNewswire
Nov 27, 2020 8:00 AM EST
PRESS RELEASES
Sorrento Announces IND Filing For COVI-DROPS, An Intranasal Formulation Of A High Potency Neutralizing Antibody Against SARS-CoV-2
By GlobeNewswire
Nov 11, 2020 9:00 AM EST
JIM CRAMER
Mad Money Recap With Jim Cramer: Still Fighting COVID-19
By Scott Rutt
Nov 10, 2020 8:25 AM EST
PRESS RELEASES
Sorrento Announces FDA IND Filing Today For COVI-AMG Neutralizing And High Potency Antibody Against SARS-CoV-2
By GlobeNewswire
Nov 9, 2020 9:00 AM EST
JIM CRAMER
Stimulus and COVID: Cramer's 'Mad Money' Recap (Thursday 10/15/20)
By Scott Rutt
Oct 15, 2020 8:47 PM EDT
PRESS RELEASES
Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared For A Phase 1 Trial By The FDA To The Pipeline Of COVID-19 Focused Rescue Therapies
By GlobeNewswire
Oct 12, 2020 5:20 PM EDT
PRESS RELEASES
Sorrento COVID-19 R&D October 13, 2020 Pipeline Call Details Released
By GlobeNewswire
Oct 9, 2020 7:46 PM EDT
PRESS RELEASES
Scilex Holding Company, A Subsidiary Of Sorrento Therapeutics, Announces Continuous Sales Growth In ZTlido® And Expects To Complete Enrollment On Its SP-102 (SEMDEXA™) Phase 3 Pivotal Trial Program In 2020
By GlobeNewswire
Oct 7, 2020 6:00 AM EDT
PRESS RELEASES
Sorrento To Host A R&D Day To Showcase COVID-19 Product Pipeline
By GlobeNewswire
Oct 4, 2020 6:39 PM EDT
PRESS RELEASES
Sorrento Therapeutics And ViralClear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
By GlobeNewswire
Sep 30, 2020 9:00 AM EDT
